As of April 29, 2025, Intensity Therapeutics (INTS) has a market cap of $9.165 million USD. According to our data, Intensity Therapeutics is ranked No.8848 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $9.17 M |
-65.52%
|
Dec 31, 2024 | $26.58 M |
-79.46%
|
Dec 29, 2023 | $0.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Iovance Biotherapeutics
IOVA
|
$1.17 B |
0.000 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$69.44 M |
0.000 M
|
![]() UK
|
![]() Cellectis
CLLS
|
$0.21 B |
48.381 M
|
![]() France
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
![]() Canada
|
![]() MacroGenics
MGNX
|
$0.10 B |
-0.000 M
|
![]() USA
|
![]() Inovio Pharmaceuticals
INO
|
$70.05 M |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$44.00 M |
0.000 M
|
![]() USA
|
![]() Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
![]() USA
|
![]() Arvinas
ARVN
|
$0.64 B |
-0.000 M
|
![]() USA
|
Market Cap | = | INTS Stock Price | * | INTS Shares Outstanding |
= | $0.60 | * | 15.18 M | |
= | $9.17 M |